Journal Home > Volume 11 , Issue 4

The objective of this study is to evaluate the suppressive effect of buckwheat-albumin hydrolysate on postprandial hyperglycemia and identify the peptide responsible to the function. Buckwheat-albumin hydrolysate was prepared by using digestive enzymes and was orally administered to rats together with soluble starch. The blood was taken from the tail vein up to 90 min after oral administration to measure blood-glucose and plasma-insulin levels. The peptide with α-amylase inhibitory activity was purified from the buckwheat-hydrolysate by gel-filtration chromatography, α-amylase affinity chromatography, and high performance liquid chromatography (HPLC). The amino-acid sequence of the peptide was identified by a protein sequencer and was compared with that in the buckwheat-genome database. Buckwheat-albumin hydrolysate significantly suppressed the elevation of blood glucose level 15 min after starch administration. The amino-acid sequence of the peptide with α-amylase inhibitory activity was YVEPDCGNLGCCYHC in the parental protein of molecular mass 17.8 kDa and theoretical pI 4.77. The amino-acid sequence, molecular weight, and pI of the parental protein in buckwheat albumin were different from those of α-amylase inhibitor in wheat albumin. This study suggests that the novel α-amylase inhibitor identified in buckwheat albumin is a potential candidate for a functional food material to suppress postprandial blood glucose elevation.


menu
Abstract
Full text
Outline
About this article

Suppression of postprandial blood glucose elevation by buckwheat (Fagpopyrum esculentum) albumin hydrolysate and identification of the peptide responsible to the function

Show Author's information Kazumi NinomiyaaYusuke YamaguchibFumie ShinmachibHitoshi KumagaiaHitomi Kumagaib( )
Department of Food Science and Nutrition, Kyoritsu Women's University, 2-2-1 Hitotsubashi, Chiyoda-ku, Tokyo 101-8347, Japan
College of Bioresource Sciences, Nihon University, 1866 Kameino, Fujisawa-shi 252-0880, Japan

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

The objective of this study is to evaluate the suppressive effect of buckwheat-albumin hydrolysate on postprandial hyperglycemia and identify the peptide responsible to the function. Buckwheat-albumin hydrolysate was prepared by using digestive enzymes and was orally administered to rats together with soluble starch. The blood was taken from the tail vein up to 90 min after oral administration to measure blood-glucose and plasma-insulin levels. The peptide with α-amylase inhibitory activity was purified from the buckwheat-hydrolysate by gel-filtration chromatography, α-amylase affinity chromatography, and high performance liquid chromatography (HPLC). The amino-acid sequence of the peptide was identified by a protein sequencer and was compared with that in the buckwheat-genome database. Buckwheat-albumin hydrolysate significantly suppressed the elevation of blood glucose level 15 min after starch administration. The amino-acid sequence of the peptide with α-amylase inhibitory activity was YVEPDCGNLGCCYHC in the parental protein of molecular mass 17.8 kDa and theoretical pI 4.77. The amino-acid sequence, molecular weight, and pI of the parental protein in buckwheat albumin were different from those of α-amylase inhibitor in wheat albumin. This study suggests that the novel α-amylase inhibitor identified in buckwheat albumin is a potential candidate for a functional food material to suppress postprandial blood glucose elevation.

Keywords: Type 2 diabetes, Buckwheat-albumin hydrolysate, Bioactive peptide, α-Amylase inhibitor, Postprandial hyperglycemia

References(36)

[1]
World Health Organization, Global Report on Diabetes (2016).
[2]

K.G.M.M. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, Provisional report of a WHO Consultation. Diabet. Med. 15 (1998) 539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

[3]

A. Cavallero, S. Empilli, F. Brighenti, et al., High (1→3,1→4)-β-glucan barley fractions in bread making and their effects on human glycemic response, J. Cereal. Sci. 33 (2002) 56-66. https://doi.org/10.1006/jcrs.2002.0454.

[4]

J.T. Braaten, P.J. Wood, F.W. Scott, et al., Oat gum lowers glucose and insulin after an oral glucose load, Am. J. Clin. Nutr. 53 (1991) 1425-1430. https://doi.org/10.1093/ajcn/53.6.1425.

[5]

T. Nishimune, T. Yakushiji, T. Sumimoto, et al., Glycemic response and fiber content of some foods, Am. J. Clin. Nutr. 54 (1991) 414-419. https://doi.org/10.1093/ajcn/54.2.414.

[6]

H.G.M. Liljeberg, Y.E. Granfeldt, I.M.E. Björck, Products based on a high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans. J. Nutr. 126 (1996) 458-466.

[7]

Y. Hara, M. Honda, The inhibition of α-amylase by tea polyphenols. Agric. Biol. Chem. 54 (1990) 1939-1945. https://doi.org/10.1080/00021369.1990.10870239.

[8]

T. Matsui, T. Tanaka, S. Tamura, et al., α-Glucosidase inhibitory profile of catechins and theaflavins, J. Agric. Food Chem. 55 (2007) 99-105. https://doi.org/10.1021/jf0627672.

[9]

V. Buonocore, T. Petrucci, V. Silano, Wheat protein inhibitors of α-amylase. Phytochemistry 16 (1977) 811-820. https://doi.org/10.1016/S0031-9422(00)86672-8.

[10]

R. Shainkin, Y. Birk, α-Amylase inhibitors from wheat. Isolation and characterization, Biochim. Biophys. Acta. 221 (1970) 502-513. https://doi.org/10.1016/0005-2795(70)90221-7.

[11]

V. Silano, F. Pocchiari, D.D. Kasarda, Physical characterization of α-amylase inhibitors from wheat, Biochim. Biophys. Acta. 317 (1973) 139-148. https://doi.org/10.1016/0005-2795(73)90206-7.

[12]

R.J. Weselake, A.W. MacGregor, R.D. Hill, et al., Purification and characteristics of an endogenous α-amylase inhibitor from barley kernels, Plant Physiol. 73 (1983) 1008-1012. https://doi.org/10.1104/pp.73.4.1008.

[13]

P.E. Granum, Purification and characterization of an α-amylase inhibitor from rye (Secale cereale) flour, J. Food Biochem. 2 (1978) 103-120. https://doi.org/10.1111/j.1745-4514.1978.tb00607.x.

[14]

A. Blanco-Labra, F.A. Iturbe-chiñas, Purification and characterization of an α-amylase inhibitor from maize (Zea maize), J. Food Biochem. 5 (1981) 1-17.

[15]

Z. Yu, Y. Yin, W. Zhao, et al., Anti-diabetic activity peptides from albumin against α-glucosidase and α-amylase, Food Chem. 135 (2012) 2078-2085.

[16]

J. Yan, J. Zhao, R. Yang, et al., Bioactive peptides with antidiabetic properties: a review, Int. J. Food Sci. Technol. 54(6) (2019) 1909-1919, https://doi.org/10.1111/ijfs.14090.

[17]

B. Svensson, K. Fukuda, P.K. Nielsen, et al., Proteinaceous α-amylase inhibitors, Biochim. Biophys. Acta. 1696 (2004) 145-156. https://doi.org/10.1016/j.bbapap.2003.07.004.

[18]

M. Lankisch, P. Layer, R. A. Rizza, et al., Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans, Pancreas 17 (2) (1998) 176-181. https://doi.org/10.1097/00006676-199808000-00011.

[19]

W. Puls, U. Keup, Influence of an α-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading test in rats, dogs and man, Diabetologia 9 (1973) 97-101. https://doi.org/10.1007/BF01230687.

[20]

H. Oneda, S. Lee, K. Inouye, Inhibitory effect of 0.19 α-amylase inhibitor from wheat kernel on the activity of porcine pancreas α-amylase and its thermal stability, J. Biochem. 135 (2004) 421-427. https://doi.org/10.1093/jb/mvh050.

[21]

S. Arai, A. Yasuoka, K. Abe, Functional food science and food for specified health use policy in Japan: State of the art, J. Lipid Res. 19 (2008) 69-73. https://doi.org/10.1097/MOL.0b013e3282f3f505.

[22]

T. Kodama, T. Miyazaki, I. Kitamura, et al., Effects of single and longterm administration of wheat albumin on blood glucose control: randomized controlled clinical trials, Eur. J. Clin. Nutr. 59 (2005) 384-392. https://doi.org/10.1038/sj.ejcn.1602085.

[23]

S. Ina, K. Ninomiya, T. Mogi, et al., Rice (Oryza sativa japonica) albumin suppresses the elevation of blood glucose and plasma insulin levels after oral glucose loading, J. Agric. Food Chem. 64 (2016) 4882-4890. https://doi.org/10.1021/acs.jafc.6b00520.

[24]

S. Ina, A. Hamada, T. Kaneko, et al., Physicochemical and surface properties of rice albumin for its application as a functional food material, Food Sci. Technol. Res. 25(4) (2019) 555-562. https://doi.org/10.3136/fstr.25.555.

[25]

S. Ina, A. Hamada, H. Nakamura, et al., Rice (Oryza sativa japonica) albumin hydrolysates suppress postprandial blood glucose elevation by adsorbing glucose and inhibiting Na+-D-glucose cotransporter SGLT1 expression, J. Funct. Foods 64 (2020) 103603. https://doi.org/10.1016/j.jff.2019.103603.

[26]

K. Ninomiya, S. Ina, A. Hamada, et al., Suppressive effect of the α-amylase inhibitor albumin from buckwheat (Fagopyrum esculentum Moench) on postprandial hyperglycaemia, Nutrients 10 (2018) 1503. https://doi.org/10.3390/nu10101503.

[27]

T.M. Wolever, D.J. Jenkins, The use of the glycemic index in predicting the blood glucose response to mixed meals, Am. J. Clin. Nutr. 43 (1986) 167-172. https://doi.org/10.1093/ajcn/43.1.167.

[28]

A.Y. Foo, R. Bais, Amylase measurement with 2-chloro-4-nitrophenyl maltotrioside as substrate, Clin. Chim. Acta 272 (1998) 137-147. https://doi.org/10.1016/S0009-8981(98)00009-6.

[29]

Y. Yasui, H. Hirakawa, M. Ueno, et al., Assembly of the draft genome of buckwheat and its applications in identifying agronomically useful genes, DNA Res. 23(3) (2016) 215-224. https://doi.org/10.1093/dnares/dsw012.

[30]
Kazusa DNA Research Institute, Buckwheat Genome Data Base (BGDB), (2015) http://buckwheat.kazusa.or.jp.
[31]
R. Westermeier, Electrophoresis in gels. In Protein Purification: Principles, High Resolution Methods, and Applications, 3rd ed., J. -C. Janson, Ed.; John Wiley & Sons, Inc., Hoboken, NJ, USA, (2011) pp. 365-377.
DOI
[32]

G.H. Feng, M. Richardson, M.S. Chen, et al., α-Amylase from wheat: amino acid sequences and patterns of inhibition of insect and human α-amylase. Insect Biochem. Mol. Biol. 26 (1996) 419-426. https://doi.org/10.1016/0965-1748(95)00087-9.

[33]

J.E. Baker, Purification of an α-amylase inhibitor from wheat, Triticum aestivum, and its interaction with amylase from the rice, weevil, Sitophilus orizae (Coleoptera: Curculionidae). Insect Biochem. 18 (1988) 107-116. https://doi.org/10.1016/0020-1790(88)90043-1.

[34]

P.P. Gadge, S.K. Wagh, F.K. Shaikh, et al., A bifunctional α-amylase/trypsin inhibitor from pigeonpea seeds: purification, biochemical characterization and its bio-efficacy against Helicoverpa armigera, Pestic. Biochem. Physiol. 125 (2015) 17-25. https://doi.org/10.1016/j.pestbp.2015.06.007.

[35]

B. F. Gibbs, I. Alli, Characterization of a purified α-amylase inhibitor from white kidney beans (Phaseolus vulgaris), Food Res. Int. 31(3) (1998) 217-225. https://doi.org/10.1016/S0963-9969(98)00074-X.

[36]

K. Maskos, M. Huber-Wunderlich, R. Glockshuber, RBI, a one-domain α-amylase/trypsin inhibitor with completely independent binding sites, FEBS Lett. 397(1) (1996) 11-16. https://doi.org/10.1016/S0014-5793(96)01131-3.

Publication history
Copyright
Rights and permissions

Publication history

Received: 01 November 2020
Revised: 13 February 2021
Accepted: 16 March 2021
Published: 28 April 2022
Issue date: July 2022

Copyright

© 2022 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return